Who Owns Inovio Pharmaceuticals Stock?
NASDAQ: INOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:23 PM ET
Ownership breakdown
- Held by institutions
- 46.02%
- Held by insiders
- 0.33%
- Institutional holders
- 118
- Institutions 46.0%
- Insiders 0.3%
- Public and other 53.7%
Who owns Inovio Pharmaceuticals stock?
Institutional investors own about 46.0% of Inovio Pharmaceuticals's shares, spread across 118 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.33% of INO.
The largest institutional holders are FMR, LLC (8.18%), Jupiter Topco LLC (5.00%) and Vanguard Capital Management LLC (3.53%). Together, the top 10 institutions control 26.6% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their INO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of INO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 8.45M | 8.18% | -9.5% |
| Jupiter Topco LLC | 5.17M | 5.00% | +100.0% |
| Vanguard Capital Management LLC | 3.65M | 3.53% | +25.8% |
| Boxer Capital Management, LLC | 2.84M | 2.75% | +20.0% |
| Adar1 Capital Management, LLC | 2.14M | 2.07% | +45.8% |
| Shaw D.E. & Co., Inc. | 1.35M | 1.31% | -38.9% |
| Two Sigma Investments, LP | 1.24M | 1.20% | +217.6% |
| Eversept Partners, LP | 1.04M | 1.00% | 0.0% |
| Geode Capital Management, LLC | 802.75K | 0.78% | +0.2% |
| Millennium Management Llc | 796.11K | 0.77% | -43.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of INO
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 6.99M | 6.76% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 3.54M | 3.42% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.60M | 2.51% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 963.33K | 0.93% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 398.40K | 0.39% |
| iShares Trust-iShares Micro-Cap ETF | 278.30K | 0.27% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 173.00K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 104.00K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 96.12K | 0.09% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 85.27K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Inovio Pharmaceuticals?
FMR, LLC is the largest institutional shareholder of INO, owning 8.18% of shares outstanding (8.45M shares) as of its latest 13F filing.
What percentage of Inovio Pharmaceuticals is owned by institutions?
Institutions own about 46.0% of INO shares and 46.2% of the public float.
How much of Inovio Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.33% of INO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.